ダウンロード数: 208

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
33_786.pdf493.24 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author萬谷, 嘉明ja
dc.contributor.author岡本, 知士ja
dc.contributor.author氏家, 隆ja
dc.contributor.author葉, 剛雄ja
dc.contributor.author野呂, 一夫ja
dc.contributor.author新里, 滋ja
dc.contributor.author横田, 季世士ja
dc.contributor.author青木, 光ja
dc.contributor.author久保, 隆ja
dc.contributor.author大堀, 勉ja
dc.contributor.alternativeBANYA, Yoshiakien
dc.contributor.alternativeOKAMOTO, Tomoshien
dc.contributor.alternativeUJIIE, Takashien
dc.contributor.alternativeYOO, Takeoen
dc.contributor.alternativeNORO, Kazuoen
dc.contributor.alternativeNIISATO, Shigeruen
dc.contributor.alternativeYOKOTA, Kiyoshien
dc.contributor.alternativeAOKI, Hikaruen
dc.contributor.alternativeKUBO, Takashien
dc.contributor.alternativeOHHORI, Tsutomuen
dc.date.accessioned2010-06-02T02:20:06Z-
dc.date.available2010-06-02T02:20:06Z-
dc.date.issued1987-05-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/119118-
dc.description.abstractCefbuperazone (CBPZ) was administered to inpatients with complicated urinary tract infections (UTI) at our department. Clinical efficacy and safety were evaluated in 22 chronic cases by the criteria for evaluation of clinical of antimicrobial agents on urinary tract infection. Overall clinical efficacy was excellent in 8 cases, moderate in 9 cases and poor in 5 cases with an effectiveness rate of 77%. Twenty-four of the 34 strains isolated from the patients were eradicated and eradication rate was 71%. Neither subjective nor objective adverse reactions were observed. Abnormal changes in laboratory tests were found in 9 patients, but were probably not related to CBPZ administration. Judging from these results, CBPZ is considered to be an effective and safe antibacterial for the treatment of complicated UTI.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher泌尿器科紀要刊行会ja
dc.subjectUrinary tract infection (UTI)en
dc.subjectCefbuperazone (CBPZ)en
dc.subject.ndc494.9-
dc.title複雑性尿路感染症に対するCefbuperazone(CBPZ)の臨床使用経験ja
dc.title.alternativeClinical experience with cefbuperazone in complicated urinary tract infectionen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume33-
dc.identifier.issue5-
dc.identifier.spage786-
dc.identifier.epage793-
dc.textversionpublisher-
dc.sortkey28-
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address岩手医科大学医学部泌尿器科学教室ja
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.address.alternativethe Department of Urology, School of Medicine, Iwate Medical Universityen
dc.identifier.pmid3661345-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.33 No.5

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。